Results 91 to 100 of about 300,077 (226)

Dysregulated iron metabolism in polycythemia vera: etiology and consequences

open access: yesLeukemia, 2018
Polycythemia vera (PV) is a chronic myeloproliferative neoplasm. Virtually all PV patients are iron deficient at presentation and/or during the course of their disease.
Y. Ginzburg   +5 more
semanticscholar   +1 more source

Coexistence of chronic lymphocytic leukemia and polycythemia vera: a case report and review of the literature

open access: yesAnnals of Saudi Medicine, 2016
Polycythemia vera is a Philadelphia chromosome-negative myeloproliferative neoplasm. Chronic lymphocytic leukemia is a monoclonal expansion of a CD5+ CD19+ B lymphocytes.
Serdal Korkmaz   +4 more
doaj   +1 more source

Polycythemia vera treatment algorithm 2018

open access: yesBlood Cancer Journal, 2018
Recently reported mature survival data have confirmed the favorable prognosis in polycythemia vera (PV), with an estimated median survival of 24 years, in patients younger than age 60 years old.
A. Tefferi, A. Vannucchi, T. Barbui
semanticscholar   +1 more source

Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?

open access: yesSeminars in Immunopathology, 2018
The first clinical trials of the safety and efficacy of interferon-alpha2 (IFN-alpha2) were performed about 30 years ago. Since then, several single-arm studies have convincingly demonstrated that IFN-alpha2 is a highly potent anti-cancer agent in ...
H. Hasselbalch, M. Holmström
semanticscholar   +1 more source

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera

open access: yesHaematologica, 2009
To further characterize JAK2 exon 12 mutations, we performed molecular screening in 409 patients with polycythemia vera or unclear erythrocytosis with unmutated JAK2V617. The frequency of JAK2exon12 mutations was 10/63 (15.9%) in PV but only 5/346 (1.4%)
Susanne Schnittger   +14 more
doaj   +1 more source

Outcomes of dengue infection in adults with underlying haematological diseases in Brazil during 2024 and 2025

open access: yes
British Journal of Haematology, Volume 209, Issue 1, Page 324-328, July 2026.
K. Tozatto‐Maio   +16 more
wiley   +1 more source

Superior Vena Cava Syndrome in a Patient with Polycytemia Vera: Diagnosis and Treatment

open access: yesCardiology Research and Practice, 2010
Polycythemia vera is a myeloproliferative disorder characterized by thrombotic complications both in the arterial and venous systems. We report the case of a 55-year-old patient affected by polycythemia vera, presenting with acute superior vena cava ...
Salvatore Lentini   +3 more
doaj   +1 more source

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

open access: yesLeukemia, 2021
G. Abu-Zeinah   +9 more
semanticscholar   +1 more source

Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study

open access: yesAnnals of Hematology, 2017
In patients with polycythemia vera (PV), an elevated JAK2 p.V617F allele burden is associated with indicators of more severe disease (e.g., leukocytosis, splenomegaly, and increased thrombosis risk); however, correlations between allele burden reductions
A. Vannucchi   +9 more
semanticscholar   +1 more source

Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers' polycythemia and polycythemia vera.

open access: yesPLoS ONE
Cigarette smoking induces relative and absolute erythrocytosis (smokers' polycythemia). In patients with smokers' polycythemia complicated by chronic obstructive pulmonary disease, the incidence and mortality rate of pulmonary embolism increase ...
Kazuhide Iizuka   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy